TherapeuticsMD (TXMD) Stock Statistics & Valuation Metrics

TherapeuticsMD has a market cap or net worth of $23.15M. The enterprise value is $19.79M.

TherapeuticsMD has 11,574,362 shares outstanding. The number of shares has decreased by -2.65% in one year.

TherapeuticsMD’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -12.82%.

The current PE Ratio of TherapeuticsMD is 61.5. TherapeuticsMD’s PEG ratio is 0.45.

In the last 12 months, TherapeuticsMD had revenue of 3.02M and earned -569.00K in profits. Earnings per share was -0.05.

In the last 12 months, operating cash flow was 2.67M and capital expenditures 0.00, giving a free cash flow of 2.67M billion.

TherapeuticsMD pays an annual dividend of ―, resulting in a dividend yield of ―

TherapeuticsMD upcoming earnings date is Aug 17, 2026, Before Open (Confirmed).

TherapeuticsMD as a current ratio of 3.02, with Debt / Equity ratio of 17.88%

In the past 12 months, TherapeuticsMD has paid 0.00 in taxes.

TherapeuticsMD EV to EBITDA ratio is -5.46, with an EV/FCF ratio of 6.81.

TherapeuticsMD has $8.42M in cash and marketable securities with $4.82M in debt, giving a net cash position of $3.60M billion.

Gross margin is 90.31%, with operating margin of -139.44%, and net profit margin of -18.83%.

The average price target for TherapeuticsMD is ―, which is 11.43% higher than the current price. The consensus rating is ―